My NCBISign In

Display Settings:

Format

Send to:

Choose Destination

    AIDS. 2005 Jul 22;19(11):1233-4.

    Instability of lopinavir/ritonavir capsules at ambient temperatures in sub-Saharan Africa: relevance to WHO antiretroviral guidelines.

    Pau AK, Moodley NK, Holland DT, Fomundam H, Matchaba GU, Capparelli EV.

    National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

    WHO recommends lopinavir/ritonavir as an antiretroviral option in resource-limited countries. Lopinavir/ritonavir is recommended to be stored at 2-8 degrees C until dispensing, and afterwards, may be kept at < or = 25 degrees C for < or = 2 months. Anticipating lopinavir/ritonavir use in countries lacking adequate cold-chains, we assessed its physical and chemical stability at 35 and 45 degrees C. Although maintaining chemical stability for 4 weeks at 35 degrees C, at 45 degrees C the capsules clumped after 7 days, supporting a need for more temperature-stable formulations for hotter climates.

    PMID: 15990580 [PubMed - indexed for MEDLINE]

    Supplemental Content

    Write to the Help Desk